文献速递皮肤肿瘤

皮肤鳞状细胞癌管理:文献综述与更新

Management of cutaneous squamous cell carcinoma: A literature review and update.
PubMed 文献 · J Am Acad Dermatol · 2025-11-18

该文献综述基于现有证据更新了皮肤鳞状细胞癌(cSCC)的评估与管理策略,涵盖可疑病灶的风险分层、影像学与前哨淋巴结活检的作用、按风险分层的治疗推荐,以及基因表达谱等新型预后工具的证据。正确的风险分层可指导治疗决策并识别可能受益于更积极治疗的肿瘤。

要点

  • cSCC是仅次于基底细胞癌的第二常见角质形成细胞癌,占所有角质形成细胞癌的20%至50%。
  • 多数低风险cSCC可仅通过手术治疗治愈,高风险肿瘤需更积极的治疗。
  • 风险分层可指导治疗决策并识别可能受益于更积极治疗的肿瘤。

核心结论

  • 正确的cSCC风险分层可指导治疗决策与管理,并识别可能受益于更积极治疗的肿瘤。

研究设计与样本

  • 文献综述与更新,检索范围未在摘要中报告。

主要发现

  • cSCC是仅次于基底细胞癌的第二常见角质形成细胞癌,占所有角质形成细胞癌的20%至50%。
  • 多数低风险cSCC可仅通过手术治疗治愈,而高风险肿瘤需要更积极的治疗。

临床怎么用

  • 对可疑cSCC病灶进行风险分层,以指导治疗决策并识别需更积极治疗的肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell carcinoma (cSCC) is the second most common keratinocyte carcinoma after basal cell carcinoma and accounts for 20% to 50% of all keratinocyte carcinomas. While most cSCCs are low risk, a subset is associated with a higher likelihood of poor outcomes, including recurrence, metastasis, and death. The majority of low-risk tumors may be cured with surgical treatment alone. However, high-risk tumors require more aggressive therapy. Here, we provide an evidence-based update surrounding the evaluation and management of cSCC. We discuss the approach to a suspicious lesion risk stratification, role of imaging and sentinel lymph node biopsy, and treatment recommendations stratified by risk. Additionally, we discuss evidence surrounding newer prognostic tools such as the gene expression profiles. Proper risk stratification of cSCCs can guide treatment decisions and management, and identify those tumors that may benefit from more aggressive therapy.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Trager MH, Gordon ER, Breneman A, et al. Management of cutaneous squamous cell carcinoma: A literature review and update. J Am Acad Dermatol. 2025. PMID: 41265752. doi:10.1016/j.jaad.2025.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。